These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35847566)

  • 1. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
    Fanucchi LC; Murphy SM; Surratt H; Kapadia SN; Walsh SL; Grubbs JA; Thornton AC; Nuzzo P; Lofwall MR
    Ther Adv Infect Dis; 2022; 9():20499361221108005. PubMed ID: 35847566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model.
    Fanucchi LC; Walsh SL; Thornton AC; Lofwall MR
    Prev Med; 2019 Nov; 128():105760. PubMed ID: 31251946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
    Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
    JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study on the use of long acting buprenorphine (
    Pineo T; Goldman JD; Swartzentruber G; Kanderi T; Qurashi H; Dimech C
    Drug Alcohol Depend Rep; 2022 Mar; 2():100020. PubMed ID: 36845901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases.
    Seval N; Eaton E; Springer SA
    Open Forum Infect Dis; 2020 Jan; 7(1):ofz539. PubMed ID: 31993454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
    Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
    Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.
    Seval N; Frank CA; Litwin AH; Roth P; Schade MA; Pavlicova M; Levin FR; Brady KT; Nunes EV; Springer SA
    Contemp Clin Trials; 2021 Jun; 105():106394. PubMed ID: 33838307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.
    Petrakis I; Springer SA; Davis C; Ralevski E; Gu L; Lew R; Hermos J; Nuite M; Gordon AJ; Kosten TR; Nunes EV; Rosenheck R; Saxon AJ; Swift R; Goldberg A; Ringer R; Ferguson R
    Addict Sci Clin Pract; 2022 Jan; 17(1):6. PubMed ID: 35101115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.
    Schramm ZA; Leroux BG; Radick AC; Ventura AS; Klein JW; Samet JH; Saxon AJ; Kim TW; Tsui JI
    Addict Sci Clin Pract; 2020 Jul; 15(1):30. PubMed ID: 32736660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.
    Marsden J; Kelleher M; Hoare Z; Hughes D; Bisla J; Cape A; Cowden F; Day E; Dewhurst J; Evans R; Hearn A; Kelly J; Lowry N; McCusker M; Murphy C; Murray R; Myton T; Quarshie S; Scott G; Turner S; Vanderwaal R; Wareham A; Gilvarry E; Mitcheson L
    Trials; 2022 Aug; 23(1):697. PubMed ID: 35986418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections.
    Fanucchi LC; Walsh SL; Thornton AC; Nuzzo PA; Lofwall MR
    Clin Infect Dis; 2020 Mar; 70(6):1226-1229. PubMed ID: 31342057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment.
    MacLean RR; Ankawi B; Driscoll MA; Gordon MA; Frankforter TL; Nich C; Szollosy SK; Loya JM; Brito L; Ribeiro MIP; Edmond SN; Becker WC; Martino S; Sofuoglu M; Heapy AA
    JMIR Res Protoc; 2024 Mar; 13():e54342. PubMed ID: 38506917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
    Tanum L; Solli KK; Latif ZE; Benth JŠ; Opheim A; Sharma-Haase K; Krajci P; Kunøe N
    JAMA Psychiatry; 2017 Dec; 74(12):1197-1205. PubMed ID: 29049469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
    Wartko PD; Bobb JF; Boudreau DM; Matthews AG; McCormack J; Lee AK; Qiu H; Yu O; Hyun N; Idu AE; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Labelle CT; Zare-Mehrjerdi M; Stotts AL; Braciszewski JM; Murphy MT; Dryden D; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Phillips RC; Shea M; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Lapham GT; Addis M; Bradley KA; ; Ghiroli MM; Hamilton LK; Hu Y; LaHue JS; Loree AM; Murphy SM; Northrup TF; Shmueli-Blumberg D; Silva AJ; Weinstein ZM; Wong MT; Burganowski RP
    JAMA Intern Med; 2023 Dec; 183(12):1343-1354. PubMed ID: 37902748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial.
    Wong JSH; Nikoo M; Westenberg JN; Suen JG; Wong JYC; Krausz RM; Schütz CG; Vogel M; Sidhu JA; Moe J; Arishenkoff S; Griesdale D; Mathew N; Azar P
    Addict Sci Clin Pract; 2021 Feb; 16(1):11. PubMed ID: 33579359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical Control.
    Serota DP; Rosenbloom L; Hervera B; Seo G; Feaster DJ; Metsch LR; Suarez E; Chueng TA; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Bartholomew TS
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac688. PubMed ID: 36632415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
    Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
    Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.